| Product NDC: | 0019-N180 |
| Proprietary Name: | GALLIUM CITRATE GA-67 |
| Non Proprietary Name: | gallium citrate ga-67 |
| Active Ingredient(s): | 2 mCi/mL & nbsp; gallium citrate ga-67 |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0019-N180 |
| Labeler Name: | Mallinckrodt Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018058 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080221 |
| Package NDC: | 0019-N180-M0 |
| Package Description: | 1 VIAL in 1 CAN (0019-N180-M0) > 6.6 mL in 1 VIAL |
| NDC Code | 0019-N180-M0 |
| Proprietary Name | GALLIUM CITRATE GA-67 |
| Package Description | 1 VIAL in 1 CAN (0019-N180-M0) > 6.6 mL in 1 VIAL |
| Product NDC | 0019-N180 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | gallium citrate ga-67 |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20080221 |
| Marketing Category Name | NDA |
| Labeler Name | Mallinckrodt Inc. |
| Substance Name | GALLIUM CHLORIDE GA-67 |
| Strength Number | 2 |
| Strength Unit | mCi/mL |
| Pharmaceutical Classes |